HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Right Ventricular Hypertrophy

Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
Also Known As:
Hypertrophy, Right Ventricular; Hypertrophies, Right Ventricular; Right Ventricular Hypertrophies; Ventricular Hypertrophies, Right; Ventricular Hypertrophy, Right
Networked: 734 relevant articles (42 outcomes, 47 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pulmonary Hypertension (Ayerza Syndrome)
2. Anoxia (Hypoxia)
3. Cardiomegaly (Heart Hypertrophy)
4. Hypertrophy
5. Fibrosis (Cirrhosis)

Experts

1. Abman, Steven H: 8 articles (12/2015 - 08/2004)
2. Laghmani, El Houari: 7 articles (08/2015 - 01/2009)
3. Walther, Frans J: 7 articles (08/2015 - 01/2009)
4. Wang, Jian: 6 articles (12/2015 - 01/2010)
5. Wagenaar, Gerry T M: 6 articles (08/2015 - 11/2010)
6. McMurtry, Ivan F: 6 articles (12/2014 - 08/2004)
7. Adnot, Serge: 6 articles (02/2014 - 05/2003)
8. Balasubramaniam, Vivek: 6 articles (07/2013 - 04/2005)
9. Chen, Ing-Jun: 5 articles (05/2015 - 05/2010)
10. Wu, Bin-Nan: 5 articles (05/2015 - 05/2010)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Right Ventricular Hypertrophy:
1. MonocrotalineIBA
2. Idiopathic pulmonary hypertensionIBA
3. sildenafil (Viagra)FDA Link
4. fasudil (AT 877)IBA
5. Simvastatin (Zocor)FDA LinkGeneric
6. carvedilol (Coreg)FDA LinkGeneric
7. rho-Associated KinasesIBA
8. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
9. Angiotensin IIIBA
10. bosentan (Tracleer)FDA Link

Therapies and Procedures

1. Bariatric Surgery
2. Ligation
3. Subcutaneous Injections
4. Aftercare (After-Treatment)
5. Catheters